The US Food and Drug Administration (FDA) has announced that starting on 1 October 2026, manufacturers must submit adverse event individual case safety reports (ICSRs) for drugs, biologics, and ...
Coffee-stained, crumpled safety reports written in illegible handwriting can be found on jobsites across the country. And if they make the journey back to the office, they are strewn about a manager's ...